PER 2.41% 8.1¢ percheron therapeutics limited

our cornerstone investor, page-6

  1. 2,110 Posts.
    Certainly encouraging, and it is relevant in my view, this is a drug from the same stable, and definitely give a bit more confidence on the outlook had the next results come positive.

    But also notice how things took their time, this is a stage II drug, the successful result were announced in January, Pfizer only moved in now 11 months later, nothing moves fast enough in the biotech world.

    Good find Cabe, I think the woody comment will stick for a while, but wait, maybe ALT1104 will come to fix that... or perhaps the lack of it.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.002(2.41%)
Mkt cap ! $73.02M
Open High Low Value Volume
8.1¢ 8.2¢ 8.0¢ $39.27K 485.4K

Buyers (Bids)

No. Vol. Price($)
1 365000 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 57142 1
View Market Depth
Last trade - 14.51pm 11/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.